Vaccines 2013, 1(4), 481-496; doi:10.3390/vaccines1040481
Review

Developing Combined HIV Vaccine Strategies for a Functional Cure

 and * email
Received: 5 September 2013; in revised form: 8 October 2013 / Accepted: 12 October 2013 / Published: 28 October 2013
(This article belongs to the Special Issue HIV Vaccines)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Increasing numbers of HIV-infected individuals have access to potent antiretroviral drugs that control viral replication and decrease the risk of transmission. However, there is no cure for HIV and new strategies have to be developed to reach an eradication of the virus or a natural control of viral replication in the absence of drugs (functional cure). Therapeutic vaccines against HIV have been evaluated in many trials over the last 20 years and important knowledge has been gained from these trials. However, the major obstacle to HIV eradication is the persistence of latent proviral reservoirs. Different molecules are currently tested in ART-treated subjects to reactivate these latent reservoirs. Such anti-latency agents should be combined with a vaccination regimen in order to control or eradicate reactivated latently-infected cells. New in vitro assays should also be developed to assess the success of tested therapeutic vaccines by measuring the immune-mediated killing of replication-competent HIV reservoir cells. This review provides an overview of the current strategies to combine HIV vaccines with anti-latency agents that could act as adjuvant on the vaccine-induced immune response as well as new tools to assess the efficacy of these approaches.
Keywords: HIV; therapeutic vaccine; CD8+ T cells; reactivation of viral reservoirs; combination therapy; functional cure
PDF Full-text Download PDF Full-Text [464 KB, uploaded 28 October 2013 09:45 CET]

Export to BibTeX |
EndNote


MDPI and ACS Style

Noto, A.; Trautmann, L. Developing Combined HIV Vaccine Strategies for a Functional Cure. Vaccines 2013, 1, 481-496.

AMA Style

Noto A, Trautmann L. Developing Combined HIV Vaccine Strategies for a Functional Cure. Vaccines. 2013; 1(4):481-496.

Chicago/Turabian Style

Noto, Alessandra; Trautmann, Lydie. 2013. "Developing Combined HIV Vaccine Strategies for a Functional Cure." Vaccines 1, no. 4: 481-496.

Vaccines EISSN 2076-393X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert